Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Kentaro Maejima is active.

Publication


Featured researches published by Kentaro Maejima.


Journal of Hepato-biliary-pancreatic Surgery | 2009

Two successful curative operations using stomach-preserving distal pancreatectomy with celiac axis resection for the treatment of locally advanced pancreatic body cancer

Satoshi Mizutani; Takeshi Shioya; Kentaro Maejima; Osamu Komine; Masanori Yoshino; Arichika Hoshino; Masao Ogata; Masanori Watanabe; Kunio Yanagimoto; Tetsuo Shibuya; Akira Tokunaga; Takashi Tajiri

Large vessel invasion is a serious factor determining whether an operation for pancreatic body cancer is feasible. The Appleby operation is a radical operation for the treatment of pancreatic body cancer that has infiltrated the celiac axis. Since this procedure includes a total gastrectomy, the operation is associated with a high morbidity, mortality, and deteriorating postoperative quality of life (QOL). We experienced two cases in which radical operations consisting of a stomach-preserving distal pancreatectomy with en bloc resection of the celiac, common hepatic, and left gastric artery were performed. The use of adjuvant chemotherapy in these cases led to a good postoperative QOL.


Esophagus | 2007

Granulocyte-colony stimulating factor-producing esophageal carcinosarcoma: a case report

Kentaro Maejima; Masanori Watanabe; Osamu Komine; Satoshi Mizutani; Hideki Bou; Akira Tokunaga; Takashi Tajiri

An 80-year-old man presented at our hospital with chest oppression and vomiting. An endoscopic examination revealed a tumor in the lower portion of the esophagus, and the patient was diagnosed as possibly having esophageal carcinosarcoma based on a histological examination of endoscopic biopsy specimens. During the initial medical examination, the patient had a high leukocyte count and a high level of serum granulocyte-colony stimulating factor (G-CSF). Moreover, immunohistochemical examination revealed cells that were positive for antibodies against G-CSF. Therefore, we diagnosed the patient as possibly having a G-CSF-producing esophageal carcinosarcoma. The patient died of tumor 4 months after the initial diagnosis.


Gastric Cancer | 2010

Chemosensitivity test for 5-fluorouracil and 5-chloro-2, 4-dihydroxypyridine predicts outcome of gastric cancer patients receiving S-1 postoperatively

Kentaro Maejima; Akira Tokunaga; Teruo Kiyama; Hitoshi Kanno; Hideki Bou; Masanori Watanabe; Hideyuki Suzuki; Eiji Uchida

BackgroundChemosensitivity tests have long been discussed but remain a topic of research. In this study, we investigated the correlation between the results of a chemosensitivity test for 5-fluorouracil and 5-chloro-2, 4-dihydroxypyridine and the clinical outcomes of gastric cancer patients treated with S-1, an oral fluoropyrimidine, as adjuvant chemotherapy.MethodsFor gastric cancer patients, we performed surgical treatment and a lymph node dissection of D2 or more. Afterwards, a chemosensitivity test for 5-fluorouracil and 5-chloro-2, 4-dihydroxypyridine was performed, using the collagen gel droplet embedded culture drug-sensitivity test (CD-DST), in surgical specimens. All the patients received postoperative adjuvant chemotherapy with S-1 for 1 year, and the overall survival (OS), relapse-free survival (RFS), and adverse events were investigated.ResultsThe chemosensitivity test was performed for 27 patients. The growth inhibition rate (IR) was 50% or more (high-sensitivity group) in 59.3% (16 cases) and it was under 50% (low-sensitivity group) in 40.7% (11 cases). The 3-year OS rate was 100% in the high-sensitivity group and 62.34% in the low-sensitivity group. The 3-year RFS rate was 83.33% in the high-sensitivity group and 24.24% in the low-sensitivity group. Thus, the 3-year OS rate and the 3-year RFS rate were higher in the high-sensitivity group than in the low-sensitivity group. No adverse events of grade 3 or greater severity were observed.ConclusionsThe results of the chemosensitivity test were correlated with the patient outcome. Therefore, such results might be useful for individualizing cancer chemotherapy and for determining future indications for postoperative adjuvant chemotherapy.


Medical Science Monitor | 2012

Surgical resection of late solitary locoregional gastric cancer recurrence in stomach bed.

Masanori Watanabe; Hideyuki Suzuki; Kentaro Maejima; Osamu Komine; Satoshi Mizutani; Masanori Yoshino; Hideki Bo; Yasuhiko Kitayama; Eiji Uchida

Summary Background Late-onset and solitary recurrence of gastric signet ring cell (SRC) carcinoma is rare. We report a successful surgical resection of late solitary locoregional recurrence after curative gastrectomy for gastric SRC carcinoma. Case Report The patient underwent total gastrectomy for advanced gastric carcinoma at age 52. Seven years after the primary operation, he visited us again with sudden onset of abdominal pain and vomiting. We finally decided to perform an operation, based on a diagnosis of colon obstruction due to the recurrence of gastric cancer by clinical findings and instrumental examinations. The laparotomic intra-abdominal findings showed that the recurrent tumor existed in the region surrounded by the left diaphragm, colon of splenic flexure, and pancreas tail. There was no evidence of peritoneal dissemination, and peritoneal lavage fluid cytology was negative. We performed complete resection of the recurrent tumor with partial colectomy, distal pancreatectomy, and partial diaphragmectomy. Histological examination of the resected specimen revealed SRC carcinoma, identical in appearance to the previously resected gastric cancer. We confirmed that the intra-abdominal tumor was a locoregional gastric cancer recurrence in the stomach bed. The patient showed a long-term survival of 27 months after the second operation. Conclusions In the absence of effective alternative treatment for recurrent gastric carcinoma, surgical options should be pursued, especially for late and solitary recurrence.


Medical Science Monitor | 2011

T tube drainage for spontaneous perforation of the extrahepatic bile duct.

Satoshi Mizutani; Aki Yagi; Masanori Watanabe; Kentaro Maejima; Osamu Komine; Masanori Yoshino; Arichika Hoshino; Masao Ogata; Hideyuki Suzuki; Akira Tokunaga; Eiji Uchida

Summary Background Spontaneous perforation of the extrahepatic bile duct is very rare. We report a patient with a spontaneous perforation of the left hepatic bile duct who was diagnosed preoperatively. Case Report A 65-year-old woman was admitted to our hospital complaining of a right upper quadrant pain lasting for two days. She was diagnosed as having a perforated bile duct and peritonitis and underwent a laparotomy. After a cholecystectomy, T-tube drainage of the left hepatic duct was performed. The postoperative course was uneventful. The T tube was removed 25 days after the surgery. Conclusions A more noninvasive procedure, such as endoscopic treatment, should play a central role in the management of extra bile duct perforation. For this case, however, we chose to perform a laparotomy based on the patient’s general condition and the presence of peritonitis. T tube decompression is effective and a safe and reliable method. The goal of treatment is to stop the bile leakage, resolve the choledocholithiasis and cholangitis, and reconstruct the bile duct.


Journal of Nippon Medical School | 2007

Significance of gastrectomy as palliative surgery for gastric carcinoma with pyloric stenosis.

Satoshi Mizutani; Takeshi Shioya; Kentaro Maejima; Masanori Yoshino; Osamu Komine; Hideki Bou; Masao Ogata; Masanori Watanabe; Tetsuo Shibuya; Akira Tokunaga; Takashi Tajiri


Journal of Nippon Medical School | 2013

Giant epidermoid cyst of the spleen with elevated CA 19-9 production managed laparoscopically: report of a case.

Arichika Hoshino; Yoshiharu Nakamura; Hideyuki Suzuki; Satoshi Mizutani; Naoto Chihara; Tetsuro Matsunobu; Kentaro Maejima; Katsuhiro Miura; Hidetsugu Hanawa; Satoshi Nomura; Tetsutaka Toyoda; Seiji Yamagishi; Ryosuke Nakata; Akira Muraki; Eiji Uchida


Clinical Journal of Gastroenterology | 2008

Four-year survival of a patient with malignant fibrous histiocytoma of the liver treated with surgery and chemotherapy

Takeshi Shioya; Ryo Yuzuriha; Kentaro Maejima; Satoshi Mizutani; Kotaro Nambu; Arichika Hoshino; Tetsuo Shibuya; Akira Tokunaga; Koshi Matsumoto; Takashi Tajiri


Journal of Nippon Medical School | 2007

Successful Use of Endoscopic Argon Plasma Coagulation for Patients with Early Gastric Cancer and Diabetes Mellitus

Masao Ogata; Kentaro Maejima; Naoto Chihara; Satoshi Mizutani; Osamu Komine; Hideki Bo; Takeshi Shioya; Masanori Watanabe; Akira Tokunaga; Takashi Tajiri


Pancreatology | 2016

Detailed examination of mesopancreas in pancreatic head carcinoma patients undergoing circumferential superior mesenteric arterial nerve plexus-preserving pancreaticoduodenectomy

Satoshi Mizutani; Hideyuki Suzuki; Takayuki Aimoto; Seiji Yamagishi; Keisuke Mishima; Akira Muraki; Makoto Sukegawa; Kohei Harigane; Kentaro Maejima; Masanori Yoshino; Masanori Watanabe; Eiji Uchida

Collaboration


Dive into the Kentaro Maejima's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Hideki Bo

Nippon Medical School

View shared research outputs
Researchain Logo
Decentralizing Knowledge